CDC panel unanimously endorses Moderna and J&J Covid boosters, sending to director for final approval

CDC panel unanimously endorses Moderna and J&J Covid boosters, sending to director for final approval

An influential Centers for Disease Control and Prevention advisory committee on Thursday unanimously recommended boosters of Moderna and Johnson & Johnson’s Covid-19 vaccines, sending it to CDC Director Dr. Rochelle Walensky for final approval.The agency’s Advisory Committee on Immunization Practices meeting recommended the Moderna booster for elderly people and at-risk adults six months after they … Read more

N.B. COVID-19 roundup: Higgs sees approval rating drop to record low 38%

N.B. COVID-19 roundup: Higgs sees approval rating drop to record low 38%

Premier Blaine Higgs’s approval rating has dropped to an all-time low amid record high COVID-19 cases, hospitalizations and deaths that followed all Public Health restrictions being lifted and the province being opened up, a new poll suggests. The Angus Reid Institute poll ranking the popularity of the provincial premiers shows Higgs has suffered a “precipitous” drop to 38 per … Read more

U.S. parents weigh risks, benefits as COVID-19 vaccine for kids nears approval

U.S. parents weigh risks, benefits as COVID-19 vaccine for kids nears approval

A child wears a face mask on the first day of New York City schools, amid the coronavirus disease (COVID-19) pandemic in Brooklyn, New York, U.S. September 13, 2021. REUTERS/Brendan McDermidSept 22 (Reuters) – In an ideal world, Leah Smithers said she could afford to wait for longer-term testing of the COVID-19 vaccines before getting … Read more

U.S. FDA advisers recommend COVID-19 boosters for 65 and older after rejecting broad approval

U.S. FDA advisers recommend COVID-19 boosters for 65 and older after rejecting broad approval

Sept 17 (Reuters) – Advisers to the U.S. Food and Drug Administration voted on Friday to recommend COVID-19 vaccine booster shots for Americans 65 and older and those at high risk of severe illness, after overwhelmingly rejecting a call for broader approval.The panel also recommended that the FDA include healthcare workers and others at high … Read more